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of Coronary Artery Calcium
Cause and Effect or Simple Association?*Paolo Raggi, MDI n this issue of iJACC, Mahabadi et al. (1) describea parallel increase of subclinical atherosclerosisand epicardial adipose tissue (EAT). Two prior
publications (2,3) reported a similar association, and
together with experimental models, they support
the role of EAT in atherosclerosis inception and
progression. In an experimental porcine model, the
investigators stripped the epicardial fat covering the
middle section of the left anterior descending
coronary artery and kept the animals alive for
3 more months on an atherosclerotic diet (4). They
also performed intravascular ultrasound imaging
before EAT stripping and just before sacriﬁcing theSEE PAGE 909animals. At the end of the experiment, they noted
that atherosclerosis had progressed in the segments
proximal and distal to the EAT resection, but not in
the coronary artery segment underlying the area
stripped of EAT. These observations contribute to an
expanding body of evidence about the role of
perivascular fat in atherosclerosis (5,6). EAT volume
is increased in patients with plaques showing signs
of vulnerability (7,8); in patients with intra-
atherosclerotic plaque hemorrhage on post-mortem
histology and in patients referred for coronary
artery bypass surgery for progressive anginal
symptoms, EAT is replete with inﬂammatory cells
and serological mediators of inﬂammation (9,10).
Several observations have demonstrated that EAT*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
of the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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relationships relevant to the contents of this paper to disclose.is associated with incident cardiovascular events
(11–13). Of interest, controlling risk factors such
as losing weight (14) or reducing low-density
lipoprotein cholesterol with statins (15) reduced EAT
volume. Hence, there seems to be consistent
evidence suggesting a link between periarterial fat
and arterial wall atherosclerosis. What separates the
current report (1) from others is the unexpected
association of progression of EAT and coronary
artery calcium (CAC) in patients with a small burden
of atherosclerosis at baseline (deﬁned as a CAC
score <100), but not in patients with more advanced
disease. In addition, the association was stronger in
younger subjects and patients with lower body mass
index. The authors interpreted these apparently
paradoxical results as an indication that epicardial
fat may have an initial promoter effect on
atherosclerosis rather than a sustained effect. The
interesting suggestion here is that not all adipose
tissue is the same and that an “aggressive behavior”
can be found in the adipose tissue of lean patients
and obese patients affected by the metabolic
syndrome alike. Is this a proof of the “healthy obese
subject” hypothesis? According to this hypothesis,
some obese individuals have a metabolically benign
proﬁle and a lower risk of cardiovascular events
than similarly obese patients with an adverse
metabolic proﬁle. Is this also a potential explanation
for the occurrence of unexpected acute coronary
events in lean subjects? Data from the Framingham
study (16) showed that EAT is associated with
coronary artery disease independent of body mass
index and waist circumference, and Gorter et al. (17)
reported a more pronounced association of EAT
with coronary artery disease severity in leaner
patients. De Larochellière et al. (18) showed that
substantial amounts of visceral adipose tissue can
be found even in nonobese individuals and are
associated with an adverse cardiometabolic proﬁle.
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918Finally, Iwayama et al. (19) found larger amounts of
EAT and a lower adiponectin concentration in the
pericardial ﬂuid of lean patients with CAD than lean
patients without CAD. In essence, a lean phenotype
is preferable, but not perfectly protective, in the
presence of a relatively large volume of visceral fat.
What is unclear, however, is why and how lean
subjects would accumulate perivascular adipose
tissue with proatherosclerotic activity, and why
would EAT not (or not as effectively) promote
progression of atherosclerosis in heavier patients and
more advanced phases of disease (1). There are even
more fundamental questions that need to be
answered: is EAT truly promoting atherosclerosis,
and if so, how does it do it? Or is it a bystander?
EAT is in direct contact with the adventitia of the
coronary arteries without the interposition of a
fascia. Paracrine effects and a dense concentration of
inﬂammatory cells in the milieu surrounding the
adventitia may stimulate the proliferation of vasa
vasorum (20). As they proliferate and expand, these
vessels penetrate the vessel wall and cause a series of
intramural hemorrhages. The cellular membrane of
erythrocytes is rich in cholesterol, and cell death in
the context of the vessel wall causes accumulation
of a large amount of lipids promoting further
inﬂammation. CAC accumulation is a very complex
process resembling bone formation, and apoptosis of
“procalcifying cells” in the vessel wall is 1 of the
necessary stimuli for its accumulation (21). According
to some researchers, the cell responsible for tissuecalciﬁcation is a smooth muscle cell, and according to
others, it is a pericyte (22). Pericytes are interspersed
with endothelial cells in the vasa vasorum
penetrating through the adventitia of vessels
developing atherosclerosis and could thus promote
some of the calciﬁcation occurring within the plaque.
Of course, the mechanisms of calciﬁcation of the
atherosclerotic plaque are much more complex than
this brief summary suggests (23), although this
explanation provides a glimpse of light on the
potential link between EAT and CAC. However, as
already mentioned, there is no obvious reason for
the different behavior seen in leaner, younger
individuals with a smaller atherosclerotic plaque
load and other patients more likely to harbor a
proatherosclerotic environment. It also remains
unknown whether expansion of EAT and/or CAC can
be inhibited or reversed and whether this will
ultimately lead to a reduction in event rates. For the
time being, the paper by Mahabadi et al. (1) adds
another piece to the growing puzzle of the impact of
visceral adipose tissue on atherosclerosis, a disease
state that continues to fascinate us while a complete
understanding of its pathogenesis continues to
elude us.
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